HCPCS L8701 is officially defined as "Powered upper extremity range of motion assist device, elbow, wrist, hand with single or double upright(s), includes microprocessor, sensors, all components and accessories, custom fabricated." HCPCS L8701 is referenced in 8 tracked payer policy changes from Sentara Health Plans, Regence BlueShield, and 5 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS L8701 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Starting January 1, 2027, Sentara Health Plans will require prior authorization for a long list of codes on Virginia commercial plans, including self-funded (ASO) plans, and for code 88380 on commercial, Medicaid and Medicare products, plus code 22860 on Medicare products. Sentara will also stop covering a separate list of codes on Virginia commercial and self-funded plans.
Medical policy DME80 sets the criteria for myoelectric upper limb prostheses and for replacement of an existing myoelectric upper limb prosthesis. Myoelectric upper limb prostheses may be medically necessary for an amputation or missing limb at the wrist or above when the listed criteria are met, including that standard body-powered prosthetic devices cannot be used or are insufficient to meet the functional needs of the individual. Upper-limb prosthetic components with both sensor and myoelectric control, and myoelectric or microprocessor controlled upper-limb orthoses, are considered investigational.
Aetna reviewed its clinical policy bulletin on robotic-assisted rehabilitation of the arms and legs (CPB 0778) on 2026-10-28. The bulletin treats robotic-assisted rehab for humeral fracture, incomplete spinal cord injury, neuromuscular disease, stroke and traumatic brain injury as experimental or unproven, and lists named devices such as IDEO, Myomo, IpsiHand, Motus, Obi, powered hip orthoses, Trexo, Walkbot and Kinova JACO as not covered. The source does not state an effective date for any change or say what changed from the prior version.
Aetna considers robotic-assisted rehabilitation of the upper limb and lower limb experimental, investigational, or unproven for indications including humeral fracture, incomplete spinal cord injury, neuromuscular diseases such as cerebral palsy, multiple sclerosis and Parkinson disease, stroke, and traumatic brain injury, because of insufficient evidence of its effectiveness. The Intrepid Dynamic Exoskeletal Orthosis (IDEO), the Myomo e100 robotic arm brace, the Myomo MyoPro2+ myoelectric limb orthosis for medical purposes, IpsiHand, Motus Hand and Foot devices, Obi robotic-assisted feeding device, powered hip orthoses for persons with spinal cord injury, Trexo Home robotic-assisted gait trainer, and Walkbot robotic-assisted gait trainer are also considered experimental, investigational, or unproven because their effectiveness has not been established. The Kinova JACO assistive robot is not covered as a personal convenience item and is not covered by Medicare.
Myoelectric upper-limb prosthetic components may be considered medically necessary when the individual has an amputation or missing limb at the wrist or above, standard body-powered devices cannot be used or are insufficient for daily activities, the remaining arm musculature meets the minimum microvolt threshold, the individual has sufficient neurologic and cognitive function, and no comorbidity interferes with the prosthesis. Advanced prostheses with both sensor and myoelectric control, such as the LUKE Arm, prostheses with individually powered digits including partial hand prostheses, and myoelectric controlled upper-limb orthoses are considered investigational. HCPCS codes A8005 and A8006 for powered cable driven grip assist gloves were added to the investigational codes on 04/01/2026.
The IHCP reviewed the Outpatient Fee Schedule, found discrepancies, and will reflect the changes in the next regular update to that schedule. Codes listed twice on previous versions will appear only once, codes missing from the schedule are covered in the outpatient setting and can be billed for dates of service on or after the date listed for each code, and other listed codes are noncovered and will be added to the schedule. Codes that have been nationally end dated will be removed from the schedule, and Current Dental Terminology (CDT) codes cannot be billed on institutional claims (UB-04 claim form or electronic equivalent).
Effective January 1, 2019, Tisagenlecleucel code Q2042 and breast MRI codes 77046, 77047, 77048 and 77049 are now reviewed by AIM Specialty Health and require prior authorization, and A9584 (iodine I-123 ioflupane) is now reviewed for medical necessity and requires prior authorization. Breast MRI codes 77058 and 77059 are no longer reviewed by AIM Specialty Health, and the CAR-T codes 0537T through 0540T are listed as not reviewed and noncovered. Effective January 4, 2019, a long list of genetic testing codes beginning with 81120 and 81121 is now reviewed by AIM Specialty Health and requires prior authorization.
Myoelectric upper limb prosthetic components are medically necessary, when benefit coverage for biomechanical or myoelectric devices is available, with documentation of ALL six criteria: an amputation or missing limb at the wrist or above, standard body-powered prosthetic devices cannot be used or are insufficient for activities of daily living, the remaining arm musculature contains the minimum microvolt threshold, sufficient neurologic and cognitive function to operate the prosthesis, no comorbidities that could interfere with function, and a functional evaluation by an independent qualified professional indicating that with training a myoelectric prosthesis is likely to meet functional needs. Myoelectric upper limb prosthetic components for other indications, advanced prostheses with both sensor and myoelectric control (such as the LUKE Arm), prostheses with individually powered digits including partial hand prostheses, and myoelectric controlled upper-limb orthoses are considered experimental or investigational when any one or more of five listed criteria are met, including lack of final approval from the FDA.
Watch L8701
Get one email when a payer policy names L8701, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.
See every payer rule for L8701
Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for L8701 in one place.
Get alerts for changes like this
Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.